Cipla Q2 Net Profit Falls 35% Amid Revenue Dip, US Sales Weaken
Cipla reported a 35% year-on-year decline in consolidated net profit to around Rs 878 crore for Q2 FY27, with revenue falling approximately 2-2.4% to about Rs 7,400 crore. The decline was driven by weaker North American sales, particularly due to competition affecting generic Revlimid, while domestic Indian revenue grew 12%. Cipla expects its upcoming product pipeline to support future growth, especially in the US market. Sequentially, revenue and operating margins showed improvement despite overall year-on-year declines.
First-hand measurement across 9 sources
We measured how 9 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (46/100). Lens Score 31/100.
Outlets measured: businessstandard, news18, economictimes, economictimes, freepressjournal, thefinancialexpress, economictimes, moneycontrol, and 1 more. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (35–62/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 27 Oct, 04:33 am. Other outlets followed.